Cite
MLA Citation
P. Ascierto et al.. “EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL).” European journal of cancer, vol. 72, n.d., pp. S128–. http://access.bl.uk/ark:/81055/vdc_100041522256.0x000018